The rash was not responsive to topical or oral corticosteroids and worsened after infliximab infusions and after subsequent administration of a second anti-TNF drug, adalimumab. Investigations.

We then used a second anti-TNF agent, adalimumab, but his rash also recurred after administration of this drug. Ultimately, our patient was sufficiently distressed with the symptoms of his rash ...

However, after the second induction dose of adalimumab he had a marked exacerbation of the same rash and adalimumab was discontinued after the first maintenance dose at the patient's request.

MD Humira (adalimumab) side effects may include pain, irritation, swelling, or itching at the site of the injection, as well ...